Navigation Links
Doctors Outraged Over Growth Hormone Controversy

Two anti-aging preventative medicine doctors say they are outraged over recent media coverage about their advocacy of prescribing human growth hormone to treat a hormone deficiency often associated with aging.

DAYTONA BEACH, Fla., April 27, 2007 /PRNewswire/ -- The adult use of human growth hormone (HGH) was at the center of a recent New York Times article about the founders of the American Academy of Anti-Aging Medicine (http://worldhealth.net/), Dr. Ronald Klatz M.D. and Dr. Robert Goldman M.D.

Writing for the New York Times, Duff Wilson reported the two physicians to be promoting the controversial hormone as an aid to extending human life span, despite claimed reports of serious side effects.

In comments to Fintan Dunne, editor of health Web site http://MyLongLife.com, the two physicians say they are outraged by a slew of recent negative media coverage on the topic. MyLongLife.com has a special report with an in-depth examination of the HGH issue and the role of established medical and pharmaceutical interests.

"There is a hidden battle going on for your right to a long, vital and healthy life," says Editor, Fintan Dunne. "Beneath the surface of this story there are hundreds of billions of dollars at stake, along with the future of medicine itself."

Dunne reports that the nascent promise of the anti-aging movement, spearheaded by the American Academy of Anti-Aging Medicine, is to greatly enhance our health as we age. However, he says that is also the worst nightmare of a pharmaceutical industry bent on easing us into premature death with a plethora of profitably expensive medications. "Viewed by entrenched medical interests, the burgeoning development of anti-aging medicine is a potent threat," says Dunne.

The special report on MyLonglife.com asks:

Is HGH real ly a dangerous drug, or a proven and safe treatment for adult growth hormone deficiency?

What lies behind the New York Times' reporting on these anti-aging preventative medicine surgeons?

Is the public being subjected to a campaign designed to discredit the field of anti-aging medicine?

Read the full story:

"True Lies About Anti-Aging and Growth Hormone"

http://MyLongLife.com/articles/True-Lies-About-AntiAging.htm

CONTACT: Fintan Dunne (Ireland) of MyLongLife.com, +353-85-732-8141, fintan@mylonglife.com

Web site: http://www.mylonglife.com/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
2. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
3. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
4. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
5. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin Emerging Growth Opportunities Conference
9. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
10. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
11. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):